Collegium Pharmaceutical

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell COLL and other ETFs, options, and stocks.

About COLL

Collegium Pharmaceutical, Inc. is a pharmaceutical company, which engages in development and planning to commercialize next generation, abuse-deterrent products for the treatment of patients suffering from chronic pain and other diseases. Its products include Xtampza ER, Nucynta ER and Nucynta IR, Belbuca, and Symproic. 

CEO
Vikram Karnani
CEOVikram Karnani
Employees
423
Employees423
Headquarters
Stoughton, Massachusetts
HeadquartersStoughton, Massachusetts
Founded
2002
Founded2002
Employees
423
Employees423

COLL Key Statistics

Market cap
1.12B
Market cap1.12B
Price-Earnings ratio
19.93
Price-Earnings ratio19.93
Dividend yield
Dividend yield
Average volume
378.39K
Average volume378.39K
High today
High today
Low today
Low today
Open price
$34.06
Open price$34.06
Volume
0.00
Volume0.00
52 Week high
$50.79
52 Week high$50.79
52 Week low
$26.72
52 Week low$26.72

Stock Snapshot

The current Collegium Pharmaceutical(COLL) stock price is $34.58, with a market capitalization of 1.12B. The stock trades at a price-to-earnings (P/E) ratio of 19.93.

On 2026-05-05, Collegium Pharmaceutical(COLL) shares started trading at $34.06, with intraday highs of — and lows of —.

Trading volume for Collegium Pharmaceutical(COLL) stock has reached 0, versus its average volume of 378.39K.

The stock's 52-week range extends from a low of $26.72 to a high of $50.79.

The stock's 52-week range extends from a low of $26.72 to a high of $50.79.

Analyst ratings

86%

of 7 ratings
Buy
85.7%
Hold
14.3%
Sell
0%

People also own

Based on the portfolios of people who own COLL. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.